Table 2.
Standardized domain scores (%).
| Domains | Domain 1 – Scope & Purpose | Domain 2 – Stakeholder Involvement | Domain 3 – Rigour of Development | Domain 4 – Clarity of Presentation | Domain 5 – Applicability | Domain 6 – Editorial Independence |
|---|---|---|---|---|---|---|
| ANTICOAG 2017 | 91.11 | 88.89 | 80.00 | 95.56 | 71.67 | 81.67 |
| ATLAS AXIS 2013 | 75.00 | 45.83 | 60.94 | 79.17 | 42.71 | 68.75 |
| BMD 2019 | 94.44 | 77.78 | 86.81 | 96.30 | 87.50 | 61.11 |
| CANPAIN DIAG 2016 | 81.94 | 65.28 | 78.13 | 77.78 | 65.63 | 79.17 |
| CANPAIN SYS CARE 2016 | 84.44 | 64.44 | 64.58 | 80.00 | 56.67 | 61.67 |
| CANPAIN TREAT 2016 | 89.81 | 7.80 | 76.63 | 94.44 | 53.47 | 72.22 |
| CCO 2016 | 70.83 | 51.39 | 61.98 | 68.06 | 54.17 | 64.58 |
| CGFS 2013 | 77.78 | 72.22 | 79.69 | 79.17 | 50.00 | 56.25 |
| CNS 2013 | 86.11 | 38.89 | 38.54 | 70.83 | 17.71 | 85.42 |
| CNS-DVT 2013 | 59.72 | 23.61 | 44.27 | 84.72 | 21.88 | 50.00 |
| CNS-FXDIS 2013 | 80.56 | 69.44 | 71.35 | 87.50 | 61.46 | 85.42 |
| CSCM 2010 | 91.67 | 69.44 | 84.90 | 90.28 | 35.42 | 56.25 |
| CSCM 2016 | 81.94 | 66.67 | 84.90 | 98.61 | 35.42 | 87.50 |
| CTS 2011 | 95.56 | 75.56 | 90.42 | 93.33 | 76.67 | 100.00 |
| CUA 2019 | 88.89 | 83.33 | 66.67 | 94.44 | 59.72 | 83.33 |
| DECOM 2017 | 83.33 | 72.22 | 81.25 | 86.11 | 68.75 | 66.67 |
| MSCC 2017 | 90.28 | 70.83 | 55.73 | 30.56 | 38.54 | 68.75 |
| GINIS 2017 | 100.00 | 98.61 | 96.88 | 93.06 | 87.50 | 89.58 |
| MRI 2017 | 84.72 | 84.72 | 92.71 | 97.22 | 70.83 | 85.42 |
| MSS 2017 | 84.72 | 70.83 | 87.76 | 87.50 | 64.06 | 83.33 |
| NASH 2018 | 91.11 | 88.89 | 80.00 | 95.56 | 71.67 | 81.67 |
| NICE 2012 | 75.00 | 45.83 | 60.94 | 79.17 | 42.71 | 68.75 |
| NICE 2016 | 81.94 | 65.28 | 78.13 | 77.78 | 65.63 | 79.17 |
| NICE PU 2014 | 84.44 | 64.44 | 64.58 | 80.00 | 56.67 | 61.67 |
| NOR 2017 | 89.81 | 7.80 | 76.63 | 94.44 | 53.47 | 72.22 |
| NPUAP 2014 | 87.50 | 81.94 | 82.81 | 94.44 | 68.75 | 97.92 |
| NUTR 2009 | 70.83 | 51.39 | 61.98 | 68.06 | 54.17 | 64.58 |
| NUWER 2011 | 77.78 | 72.22 | 79.69 | 79.17 | 50.00 | 56.25 |
| OTA 2013 | 86.11 | 38.89 | 38.54 | 70.83 | 17.71 | 85.42 |
| PALRM 2018 | 59.72 | 23.61 | 44.27 | 84.72 | 21.88 | 50.00 |
| PU-ONF 2013 | 80.56 | 69.44 | 71.35 | 87.50 | 61.46 | 85.42 |
| PU-PVA 2014 | 91.67 | 69.44 | 84.90 | 90.28 | 35.42 | 56.25 |
| REVIEW PAR 2016 | 81.94 | 66.67 | 84.90 | 98.61 | 35.42 | 87.50 |
| TIME 2017 | 95.56 | 75.56 | 90.42 | 93.33 | 76.67 | 100.00 |
| URO 2017 | 88.89 | 83.33 | 66.67 | 94.44 | 59.72 | 83.33 |
| WHO 2017 | 83.33 | 72.22 | 81.25 | 86.11 | 68.75 | 66.67 |
| WHO INT 2013 | 90.28 | 70.83 | 55.73 | 30.56 | 38.54 | 68.75 |
| WOUNDCAN 2017 | 100.00 | 98.61 | 96.88 | 93.06 | 87.5 | 89.58 |
| PVA BOWEL 2020 | 100.00 | 66.67 | 85.58 | 100.00 | 79.17 | 91.7 |
| PVA AD 2020 | 100.00 | 83.33 | 79.17 | 100.00 | 54.17 | 83.33 |
| PVA EWB 2020 | 88.89 | 72.22 | 81.25 | 94.44 | 58.33 | 91.67 |
| Median | 86.11 | 69.44 | 79.17 | 87.50 | 56.67 | 79.17 |
| Mean | 85.32 | 65.03 | 73.90 | 84.81 | 55.55 | 75.83 |